As geopolitics bring reshoring interest to a fever pitch, the United States Pharmacopeia (USP) is adding to the impetus for ...
While corticosteroid injections can be very effective at alleviating the pain and inflammation of osteoarthritis, they might ...
SLIMMERS were today warned that weight loss jabs could trigger two new side effects not listed by manufacturers. Once aimed ...
Use of GLP-1 medications linked with significantly lower total energy and protein intake among people being treated for overweight or obesity, research finds ...
U.S. pharmaceutical dependency on China poses urgent national security risks as Beijing dominates drug production and active ...
Hyderabad :In the Hyderabad police commissionerate, 189 rowdy sheeters tested positive for drugs. Following instructions from ...
In the latest tranche of published warning letters, the US Food and Drug Administration (FDA) has continued to go after ...
Novo Nordisk's CagriSema failed to achieve non-inferior weight loss versus tirzepatide in the pivotal REDEFINE-4 study. See ...
New research suggests weight-loss jabs like Ozempic may cause secret side effects including hot flushes, chills, and irregular periods ...
University of Cincinnati researchers found extended-release buprenorphine helped pregnant women avoid illegal opioids better ...
The data confirms a broader trend of surging diagnoses for mental illness, autism and ADHD, which is driving up NDIS costs and piling the pressure on Labor.
The FDA granted Priority Review to the supplemental BLA (sBLA) for efgartigimod alfa-fcab for the treatment of adults with acetylcholine receptor antibody (AChR-Ab) seronegative generalized myasthenia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results